Allabio provides a comprehensive suite of Adeno-Associated Virus (AAV) products and custom services that power advanced research and translational gene therapy programs.
Our AAV portfolio is built on a foundation of precision design, high yield, and rigorous quality control — enabling reliable gene delivery across a range of tissues and model systems.
From vector design to viral packaging and validation, Allabio offers full end-to-end AAV solutions that meet the needs of both academic and industrial clients.
Whether you require a ready-to-use reporter AAV or a fully customized vector tailored for specific tissue tropism or promoter activity, our expert team delivers high-quality results on a fast turnaround.
Core Offerings
- AAV Serotypes: AAV1–AAV9 and novel variants for CNS, retinal, muscle, and liver targeting
- Promoter Library: CAG, CMV, EF1α, hSyn, GFAP, CaMKIIα, U6, and others for tissue-specific expression
- Reporter Options: EGFP, mCherry, tdTomato, BFP, and luciferase constructs
- Packaging Services: From small-scale research grade to preclinical-scale high-titer production (≥1×10¹³ vg/mL)
- QC & Validation: Mycoplasma-free, low endotoxin, titer and purity verification via qPCR/ddPCR
- Custom Vector Design: Gene-of-interest cloning, promoter optimization, capsid selection, and functional testing
Applications
- Gene delivery and expression studies
- Functional validation of therapeutic targets
- Disease modeling in rodents and NHPs
- In vivo efficacy and biodistribution analysis
- Preclinical proof-of-concept and IND-enabling research
Why Choose Allabio
- Expert AAV design and process team with 10+ years’ experience
- Fast turnaround and scalable production
- Data-driven optimization for tissue targeting and expression balance
- Integrated consultation support from design to experimental validation